![]() |
![]() |
Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
Bank Loan Ratings | 84.64 | ACUITE A- | Stable | Reaffirmed | - |
Bank Loan Ratings | 292.61 | Not Applicable | Withdrawn | - |
Non Convertible Debentures (NCD) | 315.00 | ACUITE A- | Stable | Assigned | - |
Bank Loan Ratings | 60.00 | - | ACUITE A2+ | Reaffirmed |
Total Outstanding | 459.64 | - | - |
Total Withdrawn | 292.61 | - | - |
Rating Rationale |
Acuité has reaffirmed its long-term rating of 'ACUITE A-’ (read as ACUITE A minus) and its short-term rating of 'ACUITE A2+’ (read as ACUITE A two plus) on the Rs. 144.64 Cr. bank facilities of Gayatrishakti Paper and Boards Limited (GPBL). The outlook remains 'Stable'. Acuite has also withdrawn the long-term rating on the Rs. 47.78 Cr. bank facilities without assigning any ratings as the same are proposed facilities of Gayatrishakti Paper and Boards Limited (GPBL). The rating has been withdrawn on account of the request received from the company. The rating has been withdrawn on Acuite's policy of withdrawal of ratings as applicable to the respective instrument/facility. Rationale for reaffirmation |
About the Company |
Mumbai based, Gayatrishakti Paper and Boards Limited was founded in 1996 as a public limited company and is promoted by the G.N. Agarwal group. The company manufactures premium coated paper boards (duplex board) & kraft paper. It's duplex unit is located in Gujarat Industrial Development Corporation (GIDC) at Vapi and kraft paper unit at Sarigam. The present directors of the company are Mr. Gajendra Nagin Agarwal, Ms. Meena Gajendra Agrawal, Mr. Mahesh Narottam Jalan, Mr. Nikhar Gajendra Agarwal, Mr. Arun Kumar Lahoti, Mr. Pralhad Mansing Aher, Mr. Vinay Doulat Parashar, Mr. Mahesh Shyamnarayan Dwivedi and Ms. Suman Agarwal. |
About the Group |
Kherani Paper Mills Private Limited (KPMPL) Gayatrishakti Tissue Private Limited (GTPL)
Incorporated in 2022, GTPL is a subsidiary of GPBL, engaged in manufacturing of virgin and non-virgin tissue papers. Situated in Vapi, the plant has a manufacturing capacity of 36,000 MTPA. The company is promoted by Mr. Gajendra Nagin Agarwal and Ms. Meena Gajendra Agrawal.
|
Unsupported Rating |
Not Applicable |
Analytical Approach |
Extent of Consolidation |
•Full Consolidation |
Rationale for Consolidation or Parent / Group / Govt. Support |
To arrive at the rating, Acuité has consolidated the business and financial risk profiles of Gayatrishakti Paper and Boards Limited (GPBL), Kherani paper Mills Private Limited (KPMPL) and Gayatrishakti Tissue Private Limited (GTPL), hereinafter referred to as G.N. Agarwal group. The consolidation is on account of common management, significant crossholdings, a similar line of business and significant financial linkages among the three entities. |
Key Rating Drivers |
Strengths |
Established track record of operations and experienced management GPBL is the flagship company of the G. N. Agarwal group, which is engaged in the manufacturing of premium coated paper boards (duplex boards). The chairman and managing director of the company, Mr. G. N. Agarwal, has been associated with the paper industry for more than three decades. The extensive experience of the promoters and the management has helped the company build a strong presence in the market thereby establishing healthy relationships with its consumers. The group has an established track record with large distribution network of dealers providing access to a wide range of packaging industries such as food products, personal care, FMCG products, oral care and hygiene products, and the e-commerce industry, among others. Stable operating performance While the volumes of the paper business have declined marginally due to cheap imports, the operating revenue of group improved to Rs. 1,152.04 Cr. in FY2025 (Prov.) as against Rs. 1,049.59 Cr. in FY2024, majorly on account of commencement of commercial operations of GTPL’s tissue plant in November 2024. The operating margin also improved to 11.49 percent in FY2025 (Prov.) from 10.59 percent in FY2024 due to decline in material and power costs and better realisations (especially in the tissue business). The PAT margin stood at 3.31 percent in FY2025 (Prov.) as against 2.34 percent in FY2024. Improving financial risk profile The tangible networth of the group improved to Rs. 346.00 Cr. on March 31, 2025 (Prov.) from Rs. 257.41 Cr. on March 31, 2024 on account of equity infusion in GPBL and GTPL (~Rs. 26.52 Cr.) and accretion of profits. This increase in networth has led to a marginal decline in the gearing which stood at 1.93 times on March 31, 2025 (Prov.) as against 1.99 times on March 31, 2024 (Prov.). The TOL/TNW levels also stood improved at 2.70 times as against 3.09 times on March 31, 2024. However, the debt protection metrics stood moderate with Debt-EBITDA levels of 4.96 times on March 31, 2025 (Prov.) (4.57 times on March 31, 2024), interest coverage ratio (ICR) of 2.45 times in FY2025 (Prov.) (2.43 times in FY2024) and debt service coverage ratio (DSCR) of 1.06 times in FY2025 (Prov.) (0.96 times in FY2024) respectively. Moreover, in April 2025, GPBL raised NCDs of Rs 315 Cr. with an elongated maturity period upto 2033 to refinance its existing debt and utilise for working capital requirements. Therefore, with increasing accruals and elongation of the repayment period through NCDs, the overall financial risk profile of the group is expected to improve further. |
Weaknesses |
Working capital intensive operations
The operations of the group are working capital intensive, as evident from GCA (gross current assets) of 138 days on March 31, 2025 (Prov.) as against 114 days on March 31, 2024. The GCA are majorly driven by high inventory and debtor days which stood at 60 days each on March 31, 2025 (Prov.) (51 days and 56 days respectively on March 31, 2024) to maintain the requisite stock and customer relations. Further, the overall bank limit utilisation stood at 81.39 percent for the last six months ended March 2025. The current ratio of the group stood at 1.36 times on March 31, 2025 (Prov.).
Going forward, restriction in elongation of the working capital cycle will be a key rating sensitivity.
|
ESG Factors Relevant for Rating |
On the environment front, group has restored to clean sources of energy like solar power for running its plants to save power emissions. In its new tissue manufacturing facility, the group has installed a waste to energy boiler, which uses plastic waste to generate steam. Further, the group has an effluent treatment plant system for treatment of water. On the social front, the group has developed healthy employment practices such as insurance benefits, health and safety policies, corporate social responsibility programs for upskilling, vocational training, gender equality and rural development. It also promotes gender diversity and inclusivity. |
Rating Sensitivities |
|
All Covenants |
|
Liquidity Position |
Adequate |
The adequate liquidity position of the group is supported by the generation of net cash accruals (NCAs) of Rs. 70.91 Cr. against maturing repayment obligations of Rs. 64.03 Cr. in FY2025 (Prov.). Going forward, the NCAs are expected to remain in the range of Rs. 80 – 95 Cr. with maturing repayments in the range of Rs. 18 – 34 Cr. for FY2026 and FY2027. Further, the group had a cash and bank balance of Rs. 19.64 Cr. on March 31, 2025 (Prov.). |
Outlook: Stable |
|
Other Factors affecting Rating |
None |
Particulars | Unit | FY 25 (Provisional) | FY 24 (Actual) |
Operating Income | Rs. Cr. | 1152.04 | 1049.59 |
PAT | Rs. Cr. | 38.14 | 24.56 |
PAT Margin | (%) | 3.31 | 2.34 |
Total Debt/Tangible Net Worth | Times | 1.93 | 1.99 |
PBDIT/Interest | Times | 2.45 | 2.43 |
Status of non-cooperation with previous CRA (if applicable) |
Not Applicable |
Interaction with Audit Committee anytime in the last 12 months (applicable for rated-listed / proposed to be listed debt securities being reviewed by Acuite) |
Not applicable |
Any Other Information |
None |
Applicable Criteria |
• Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm • Consolidation Of Companies: https://www.acuite.in/view-rating-criteria-60.htm • Default Recognition: https://www.acuite.in/view-rating-criteria-52.htm • Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm |
Note on complexity levels of the rated instrument |
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
*Annexure 2 - List of Entities (applicable for Consolidation or Parent / Group / Govt. Support) | ||||||||
|
||||||||
Contacts |
About Acuité Ratings & Research |
© Acuité Ratings & Research Limited. All Rights Reserved. | www.acuite.in |